Ajanta Pharma Limited has informed the Exchange about Transcript
AJANTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ajanta Pharma has informed the stock exchanges that the written transcript of its Q1 FY2025-26 earnings call, held on 28th July 2025 at 4:00 p.m., has been uploaded on the company's website. The filing is being made under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. The transcript can be accessed through the link provided in the filing. No specific financial figures or management commentary is disclosed in this particular filing.
This is a routine compliance disclosure and has no direct material impact on the stock. Investors seeking insights into Q1 performance and management outlook should review the actual transcript linked in the filing.